P20.21.A SPINAL CORD ASTROBLASTOMA WITH EWSR1-BEND2 FUSION IN FEMALE PATIENTS: A REPORT OF FOUR CASES FROM CHINA AND A COMPREHENSIVE LITERATURE REVIEW

L Fu,W Hu,S Xi
DOI: https://doi.org/10.1093/neuonc/noae144.408
2024-10-01
Neuro-Oncology
Abstract:Abstract BACKGROUND Astroblastoma is an extremely rare central nervous system (CNS) tumor characterized by astroblastic pseudorosettes and vascular hyalinization. Despite these histologic hallmarks, its morphology can vary, occasionally resembling other CNS tumors like ependymoma. A novel tumor entity, astroblastoma, meningioma 1 (MN1)-altered, has been identified, featuring MN1 gene rearrangements typically involving BEN-domain containing 2 (BEND2) as a fusion partner. Most astroblastomas arise in the cerebral hemisphere. MATERIAL AND METHODS We present four cases of female patients with astroblastoma, focusing on their uncommon spinal cord location and the unique molecular feature of EWSR1-BEND2 fusion. All cases underwent next-generation sequencing (NGS), RNA sequencing (RNA-seq), and fluorescence in situ hybridization (FISH). Additionally, two cases underwent DNA methylation profiling. RESULTS These tumors displayed growth patterns akin to traditional intracranial astroblastomas, with three cases demonstrating high-grade histology, including elevated mitotic activity and necrosis. Interestingly, some cases exhibited positive staining for pan-cytokeratin (CK) and hormone receptors. Three out of the four patients experienced recurrence, underscoring the aggressive nature of this disease. CONCLUSION We suggest recognizing a new molecular subgroup of spinal astroblastoma and recommend testing newly diagnosed infratentorial astroblastomas for EWSR1-BEND2 fusion.
oncology,clinical neurology
What problem does this paper attempt to address?